RGLS SEC Form 4 filings
Regulus Therapeutics Inc. Latest Insider Trading Activity
Our insider trading activity tracker for Regulus Therapeutics Inc. shows 12 total open-market insider transactions for RGLS over the past 1,981 days. The most recent displayed transaction was on January 30, 2025, when Hagan Joseph P (Regulus Therapeutics Inc. Chief Executive Officer) reported a purchase of 50,000 shares at $1.09 per share. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.
Insider Trading For RGLS Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RGLS | 2025-01-31 | 2025-01-30 | Regulus Therapeutics Inc. | Hagan Joseph P | Chief Executive Officer | Buy | 1 | 50,000 | $1.09 | $54,500.00 | 19.17% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction RGLS | 2025-01-15 | 2025-01-14 | Regulus Therapeutics Inc. | Hagan Joseph P | Chief Executive Officer | Sell | 2 | 127,054 | $1.26 | $160,088.04 | 22.67% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction RGLS | 2025-01-15 | 2025-01-14 | Regulus Therapeutics Inc. | Calsada Crispina | Chief Financial Officer | Sell | 2 | 43,804 | $1.26 | $55,193.04 | 31.32% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RGLS | 2024-07-29 | 2024-07-25 | Regulus Therapeutics Inc. | Collier Kathryn J | Director | Buy | 1 | 4,000 | $1.82 | $7,280.00 | 59.35% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RGLS | 2024-01-18 | 2024-01-18 | Regulus Therapeutics Inc. | Hagan Joseph P | Chief Executive Officer | Sell | 1 | 14,580 | $1.19 | $17,350.20 | 20.34% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RGLS | 2022-03-01 | 2022-03-01 | Regulus Therapeutics Inc. | Drygin Denis | Chief Scientific Officer | Buy | 1 | 76,686 | $0.23 | $17,637.78 | 76.69% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RGLS | 2022-02-07 | 2022-02-04 | Regulus Therapeutics Inc. | Drygin Denis | Chief Scientific Officer | Buy | 1 | 23,314 | $0.23 | $5,362.22 | 100.00% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. RGLS | 2022-01-26 | 2022-01-26 | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Buy | 1 | 100,000 | $0.22 | $22,000.00 | 23.98% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RGLS | 2021-05-17 | 2021-05-17 | Regulus Therapeutics Inc. | Aker Christopher Ray | Sr. VP & General Counsel | Sell | 1 | 860 | $0.89 | $765.40 | 2.02% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting RGLS | 2021-04-16 | 2021-02-16 | Regulus Therapeutics Inc. | Hagan Joseph P | President and CEO | Sell | 1 | 4,144 | $1.72 | $7,127.68 | 1.67% | View Filing |
⚠️ THE SAMPLE ABOVE IS DEFERRED BY 6 HOURS ⚠️
Start your 2-week, no-credit-card free trial today to receive get down to the second insider trading updates in this directory or email.
Pricing
Free Trial
10 trading days$0
Explore every Premium feature before you pay.
- Full platform access
- 10 trading days
- No credit card required
- 20 years of alert history
- Live alert directory updates
Standard Monthly
Scheduled$19.99 / month
Scheduled alerts with complete trade context.
- Email and Telegram delivery
- Alert intervals from every sixty minutes to once daily
- Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
- Highlighted cluster transactions and SEC filing links
- Access to the alert directory hourly refreshes
Premium Monthly
Recommended$29.99 / month
Fastest alerts with ticker-level control.
- Everything in Standard
- Instant delivery detection-to-outbound time averages 0.90 seconds
- Alert intervals starting from one minute
- Real time alert directory updates
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.